Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin Infusion for Ventricular Infarction Limitation

NCT02565147 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT02565147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02565147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin Infusion for Ventricular Infarction Limitation
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Terminated
Start date
December 19, 2014
Completion date
June 14, 2016
Enrollment
78 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction